Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$31.57 - $37.73 $41,609 - $49,728
-1,318 Reduced 11.27%
10,378 $387,000
Q1 2023

May 15, 2023

SELL
$29.72 - $41.45 $6,597 - $9,201
-222 Reduced 1.86%
11,696 $373,000
Q4 2022

Feb 13, 2023

BUY
$30.23 - $38.71 $360,281 - $461,345
11,918 New
11,918 $425,000
Q2 2022

Aug 08, 2022

SELL
$20.97 - $37.47 $139,953 - $250,074
-6,674 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$34.38 - $65.77 $12,926 - $24,729
-376 Reduced 5.33%
6,674 $246,000
Q4 2021

Feb 14, 2022

BUY
$63.78 - $97.86 $41,584 - $63,804
652 Added 10.19%
7,050 $498,000
Q1 2021

May 14, 2021

SELL
$23.17 - $38.3 $2,154 - $3,561
-93 Reduced 1.43%
6,398 $463,000
Q4 2020

Feb 12, 2021

BUY
$18.28 - $23.85 $118,655 - $154,810
6,491 New
6,491 $308,000

Others Institutions Holding INMD

About InMode Ltd.


  • Ticker INMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,081,104
  • Market Cap $1.45B
  • Description
  • InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedur...
More about INMD
Track This Portfolio

Track Spears Abacus Advisors LLC Portfolio

Follow Spears Abacus Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spears Abacus Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spears Abacus Advisors LLC with notifications on news.